Pliant Therapeutics Inc. (PLRX): Price and Financial Metrics
PLRX Price/Volume Stats
| Current price | $13.21 | 52-week high | $19.62 |
| Prev. close | $13.30 | 52-week low | $10.22 |
| Day low | $13.07 | Volume | 1,882,800 |
| Day high | $13.85 | Avg. volume | 469,343 |
| 50-day MA | $14.08 | Dividend yield | N/A |
| 200-day MA | $13.14 | Market Cap | 803.88M |
PLRX Stock Price Chart Interactive Chart >
Pliant Therapeutics Inc. (PLRX) Company Bio
Pliant Therapeutics, Inc. engages in the business of developing and commercializing novel therapies for fibrotic diseases. It offers product discovery engine. The company is pursuing drug development programs for a range of fibrotic diseases, focusing on tissue-specific integrin modulation and TGF-ß1 signaling inhibition. Pliant Therapeutics was founded by Bradley Backes, Bill De Grado, Hal Chapman, and Dean Sheppard in June 2015 and is headquartered in South San Francisco, CA.
PLRX Price Returns
| 1-mo | 2.80% |
| 3-mo | 8.81% |
| 6-mo | 16.39% |
| 1-year | -23.51% |
| 3-year | -13.83% |
| 5-year | N/A |
| YTD | -27.06% |
| 2023 | -6.31% |
| 2022 | 43.19% |
| 2021 | -40.58% |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...